Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 1997

View Archived Issues

Sankyo prepares ACAT inhibitors

Sumitomo reveals antipsychotic agents with reduced side effects

Taiho discloses antiangiogenic agents

Hypoglycemic/hypolipidemic agents from Kyorin

Novel antibiotic isolated by Kitasato Institute and Chinese Academy of Medical Science

Kitasato Institute discovers inhibitor of IL-6 activity

Cysteine protease inhibitors described by Senju

Novel recombinant protein for bone diseases from Hoechst

Fujisawa obtains natural antifungal agent

PGD2 antagonists claimed by Shionogi

Research on cardiovascular drugs reported at the meeting of the Japanese Circulation Society

Antidepressant effects of NKH-477

ME-3167 heading for NDA submission

Meiji Seika antibiotic scheduled for launch in Europe in 1998

Novel antipsychotic agent reported by Asahi Chemical

DepoTech's new formulation of morphine sulfate enters phase I

Cor Therapeutics receives nonapprovable letter for Integrilin NDA

Cubist Pharmaceuticals and Genzyme enter compound library screening collaboration

Aphton issued U.S. patents covering Gastrimmune

Synsorb Cd enters phase II

Cangene signs distribution agreement for WinRho SDF

Biogen licenses Hirulog

Luvox cleared for OCD in children and adolescents

Axcan receives approvable letter for URSO from FDA

U.S. patent covers Connetics TCR vaccine technology

Biological role of CD39 uncovered by Immunex and collaborators

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Sex differences shape gene activity across the human brain
BioWorld
Genes that are switched on or off in the human brain differ between men and women. Moreover, these differences are not uniform. They vary across cortical regions...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
Gilead Sciences patents new GTPase KRAS G12D inhibitors
BioWorld Science
Gilead Sciences Inc. has disclosed new GTPase KRAS G12D mutant inhibitors potentially useful for the treatment of cancer.